BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 18619669)

  • 1. Progress in matrix metalloproteinase research.
    Murphy G; Nagase H
    Mol Aspects Med; 2008 Oct; 29(5):290-308. PubMed ID: 18619669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases.
    Zitka O; Kukacka J; Krizkova S; Huska D; Adam V; Masarik M; Prusa R; Kizek R
    Curr Med Chem; 2010; 17(31):3751-68. PubMed ID: 20846107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metalloproteinases. Structure and function].
    Lipka D; Boratyński J
    Postepy Hig Med Dosw (Online); 2008 Jul; 62():328-36. PubMed ID: 18614970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
    Visse R; Nagase H
    Circ Res; 2003 May; 92(8):827-39. PubMed ID: 12730128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and function of matrix metalloproteinases and TIMPs.
    Nagase H; Visse R; Murphy G
    Cardiovasc Res; 2006 Feb; 69(3):562-73. PubMed ID: 16405877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.
    Maskos K; Bode W
    Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases in tumor invasion.
    Johansson N; Ahonen M; Kähäri VM
    Cell Mol Life Sci; 2000 Jan; 57(1):5-15. PubMed ID: 10949577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural bases for substrate and inhibitor recognition by matrix metalloproteinases.
    Aureli L; Gioia M; Cerbara I; Monaco S; Fasciglione GF; Marini S; Ascenzi P; Topai A; Coletta M
    Curr Med Chem; 2008; 15(22):2192-222. PubMed ID: 18781944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of matrix metalloproteinases in normal and disease processes.
    McDonnell S; Morgan M; Lynch C
    Biochem Soc Trans; 1999 Aug; 27(4):734-40. PubMed ID: 10917674
    [No Abstract]   [Full Text] [Related]  

  • 10. Structural studies on MMPs and TIMPs.
    Bode W; Maskos K
    Methods Mol Biol; 2001; 151():45-77. PubMed ID: 11217319
    [No Abstract]   [Full Text] [Related]  

  • 11. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
    Wang X; Khalil RA
    Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
    Bode W; Maskos K
    Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of the inhibition of matrix metalloproteinases by tissue inhibitor of metalloproteinases (TIMP).
    Hutton M; Willenbrock F
    Methods Mol Biol; 2001; 151():519-32. PubMed ID: 11217325
    [No Abstract]   [Full Text] [Related]  

  • 14. Matrix metalloproteinases in vascular physiology and disease.
    Siefert SA; Sarkar R
    Vascular; 2012 Aug; 20(4):210-6. PubMed ID: 22896663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of human and mouse matrix metalloproteinase families.
    Jackson BC; Nebert DW; Vasiliou V
    Hum Genomics; 2010 Feb; 4(3):194-201. PubMed ID: 20368140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular turnover and extracellular matrix remodeling in female reproductive tissues: functions of metalloproteinases and their inhibitors.
    Fata JE; Ho AT; Leco KJ; Moorehead RA; Khokha R
    Cell Mol Life Sci; 2000 Jan; 57(1):77-95. PubMed ID: 10949582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
    Briasoulis A; Tousoulis D; Papageorgiou N; Kampoli AM; Androulakis E; Antoniades C; Tsiamis E; Latsios G; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1214-21. PubMed ID: 22519451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis.
    Khasigov PZ; Podobed OV; Gracheva TS; Salbiev KD; Grachev SV; Berezov TT
    Biochemistry (Mosc); 2003 Jul; 68(7):711-7. PubMed ID: 12946252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method for Analysis of Matrix Degradation by CCN2 Through the MMP/TIMP System.
    McLennan SV; Min D; Wang X; Twigg SM
    Methods Mol Biol; 2017; 1489():523-532. PubMed ID: 27734403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RECK, a novel matrix metalloproteinase regulator.
    Meng N; Li Y; Zhang H; Sun XF
    Histol Histopathol; 2008 Aug; 23(8):1003-10. PubMed ID: 18498076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.